Literature DB >> 10846089

A carboxy-terminally truncated form of the human immunodeficiency virus type 1 Vpr protein induces apoptosis via G(1) cell cycle arrest.

M Nishizawa1, M Kamata, R Katsumata, Y Aida.   

Abstract

Viral protein R (Vpr) of human immunodeficiency virus type 1 inhibits cell proliferation by arresting the cell cycle at the G(2) phase and inducing to apoptosis after G(2) arrest. We have reported previously that C81, a carboxy-terminally truncated form of Vpr, interferes with cell proliferation via a novel pathway that is distinct from G(2) arrest. However, the mechanism of this effect of C81 is unknown. We demonstrate here that C81 can induce apoptosis via G(1) arrest of the cell cycle. Immunostaining for various markers of stages of the cell cycle and flow cytometry analysis of DNA content showed that most HeLa cells that had been transiently transfected with a C81 expression vector were arrested at the G(1) phase and not at the G(2) or S phase of the cell cycle. Staining for annexin V, which binds phosphatidylserine on the plasma membrane, as an early indicator of apoptosis and measurement of the activity of caspase-3, a signaling molecule in apoptotic pathways, indicated that C81 is a strong inducer of apoptosis. Expression of C81 induced the condensation, fragmentation, and clumping of chromatin that are typical of apoptosis. Furthermore, the kinetics of the C81-induced G(1) arrest were closely correlated with changes in the number of annexin V-positive cells and the activity of caspase-3. Replacement of Ile or Leu residues by Pro at positions 60, 67, 74, and 81 within the leucine zipper-like domain of C81 revealed that Ile60, Leu67, and Ile74 play important roles both in the C81-induced G(1) arrest and in apoptosis. Thus, it appears that C81 induces apoptosis through pathways that are identical to those utilized for G(1) arrest of the cell cycle. It has been reported that Ile60, Leu67, and Ile74 also play an important role in the C81-induced suppression of growth. These results suggest that the suppression of growth induced by C81 result in apoptosis that is independent of G(2) arrest of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10846089      PMCID: PMC112104          DOI: 10.1128/jvi.74.13.6058-6067.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

Review 1.  Death receptors: signaling and modulation.

Authors:  A Ashkenazi; V M Dixit
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

2.  Human immunodeficiency virus type 1 Vpr gene product prevents cell proliferation on mouse NIH3T3 cells without the G2 arrest of the cell cycle.

Authors:  Y Nishino; T Myojin; M Kamata; Y Aida
Journal:  Biochem Biophys Res Commun       Date:  1997-03-17       Impact factor: 3.575

3.  Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest.

Authors:  S A Stewart; B Poon; J B Jowett; I S Chen
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

Review 4.  p53 and ATM: cell cycle, cell death, and cancer.

Authors:  S E Morgan; M B Kastan
Journal:  Adv Cancer Res       Date:  1997       Impact factor: 6.242

5.  Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice.

Authors:  Z Hanna; D G Kay; N Rebai; A Guimond; S Jothy; P Jolicoeur
Journal:  Cell       Date:  1998-10-16       Impact factor: 41.582

6.  Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors.

Authors:  M Gasmi; J Glynn; M J Jin; D J Jolly; J K Yee; S T Chen
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing.

Authors:  C R Casella; E L Rapaport; T H Finkel
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway.

Authors:  G Zauli; D Gibellini; P Secchiero; H Dutartre; D Olive; S Capitani; Y Collette
Journal:  Blood       Date:  1999-02-01       Impact factor: 22.113

9.  Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways.

Authors:  Y Jenkins; M McEntee; K Weis; W C Greene
Journal:  J Cell Biol       Date:  1998-11-16       Impact factor: 10.539

10.  Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8.

Authors:  S R Bartz; M Emerman
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more
  19 in total

1.  The first HxRxG motif in simian immunodeficiency virus mac239 Vpr is crucial for G(2)/M cell cycle arrest.

Authors:  Sandra M Mueller; Sabine M Lang
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways.

Authors:  Claire Maudet; Matthieu Bertrand; Erwann Le Rouzic; Hichem Lahouassa; Diana Ayinde; Sébastien Nisole; Caroline Goujon; Andrea Cimarelli; Florence Margottin-Goguet; Catherine Transy
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

3.  Cell-based chemical genetic screen identifies damnacanthal as an inhibitor of HIV-1 Vpr induced cell death.

Authors:  Masakazu Kamata; Raymond P Wu; Dong Sung An; Jonathan P Saxe; Robert Damoiseaux; Michael E Phelps; Jing Huang; Irvin S Y Chen
Journal:  Biochem Biophys Res Commun       Date:  2006-08-02       Impact factor: 3.575

4.  Two putative alpha-helical domains of human immunodeficiency virus type 1 Vpr mediate nuclear localization by at least two mechanisms.

Authors:  M Kamata; Y Aida
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 Vpr binds to the N lobe of the Wee1 kinase domain and enhances kinase activity for CDC2.

Authors:  Masakazu Kamata; Nobumoto Watanabe; Yoshiko Nagaoka; Irvin S Y Chen
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

Review 6.  Therapeutic Potential of Spirooxindoles as Antiviral Agents.

Authors:  Na Ye; Haiying Chen; Eric A Wold; Pei-Yong Shi; Jia Zhou
Journal:  ACS Infect Dis       Date:  2016-05-05       Impact factor: 5.084

7.  Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production.

Authors:  Eric Y Chan; Wei-Jun Qian; Deborah L Diamond; Tao Liu; Marina A Gritsenko; Matthew E Monroe; David G Camp; Richard D Smith; Michael G Katze
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

8.  Cell-surface processing of extracellular human immunodeficiency virus type 1 Vpr by proprotein convertases.

Authors:  Yong Xiao; Gang Chen; Jonathan Richard; Nicole Rougeau; Hongshan Li; Nabil G Seidah; Eric A Cohen
Journal:  Virology       Date:  2007-12-03       Impact factor: 3.616

9.  Novel nuclear import of Vpr promoted by importin alpha is crucial for human immunodeficiency virus type 1 replication in macrophages.

Authors:  Yuko Nitahara-Kasahara; Masakazu Kamata; Takuya Yamamoto; Xianfeng Zhang; Yoichi Miyamoto; Koho Muneta; Sayuki Iijima; Yoshihiro Yoneda; Yasuko Tsunetsugu-Yokota; Yoko Aida
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

10.  The human immunodeficiency virus type 1 Vpr protein and its carboxy-terminally truncated form induce apoptosis in tumor cells.

Authors:  Mizuho Nonaka; Yoshie Hashimoto; Shin-Nosuke Takeshima; Yoko Aida
Journal:  Cancer Cell Int       Date:  2009-08-12       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.